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One of the unique characteristics of higher organisms is their ability to learn and adapt to changes in their
environment. This plasticity is largely a result of the brain’s ability to convert transient stimuli into long-lasting
alterations in neuronal structure and function. This process is complex and involves changes in receptor traf-
ficking, local mRNA translation, protein turnover, and new gene synthesis. Here, we review how neuronal
activity triggers calcium-dependent gene expression to regulate synapse development, maturation, and
refinement. Interestingly, many components of the activity-dependent gene expression program are mutated
in human cognitive disorders, which suggest that this program is essential for proper brain development and
function.Introduction
Mammalian nervous system development occurs through an
intricate genetic program that ensures that the diverse types of
neurons and glia that make up the brain are generated in the
correct number and migrate to the appropriate place by the
time of the birth of the organism. However, sensory, cognitive,
and motor experiences also play a key role in shaping neuronal
circuitry by affecting the development and maturation of synap-
tic connections during postnatal nervous system development.
Later in life, sensory experiences also affect synaptic function
leading to the formation of long-lasting memories and alterations
in the behavior of adult organisms. The importance of environ-
mental cues for the development of the nervous system was
demonstrated by the elegant work of Hubel and Wiesel in the
visual system, which revealed that experience plays a critical
role in shaping neuronal connectivity (Wiesel, 1982).
The effects of the environment on brain development are man-
ifested through the release of neurotransmitters at specific syn-
apses, which, following binding to appropriate receptors on the
postsynaptic neuron, induce a number of biochemical signaling
events in the postsynaptic neuron. One of the most prominent
of these signaling events is a rapid and transient rise in calcium
levels within the postsynaptic specialization. This local increase
in calcium concentration can, depending on the cellular context,
result in a number of short-term and long-term synapse-specific
alterations, including the insertion or removal of glutamate recep-
tor subunits from the membrane, the alteration of synaptic protein
function via posttranslational modifications such as phosphory-
lation, and the stimulation of the translation or degradation of pro-
teins at the synapse, which together lead to changes in synaptic
function (reviewed in this issue of Neuron: Catterall and Few,
2008; Higley and Sabatini, 2008; Wayman et al., 2008b).
In addition to these local changes at the synapse, calcium in-
flux into the postsynaptic neuron initiates a cascade of signaling846 Neuron 59, September 25, 2008 ª2008 Elsevier Inc.events that culminates in the nucleus and results in the activation
of a program of gene expression that promotes dendritic growth,
synapse development, and neuronal plasticity. In this review, we
will begin by describing initial studies revealing that calcium
signaling in neurons induces gene transcription within the nu-
cleus. We will discuss how an increase in intracellular calcium
concentration is interpreted by the neuron and how this signal
is propagated to the nucleus to induce the transcription of spe-
cific genes. We will then review how the newly synthesized
mRNAs and proteins act within the neuron to affect synaptic
development and plasticity. Finally, we will conclude with a dis-
cussion of how this program of activity-dependent gene tran-
scription is important for organismal behavior and how mutation
of components of this genetic program result in human cognitive
disorders, including autism spectrum disorders.
Discovery that Transcription Can Be Induced
by Neuronal Activity
The first clue that there might be genes whose expression is
regulated by neuronal activity came from the observation that
agonists of the nicotinic acetylcholine receptor, and other agents
that induce membrane depolarization and the subsequent influx
of calcium into cells through L-type VSCCs, trigger the rapid and
transient activation of the c-fos proto-oncogene in neuronal cell
lines (Greenberg et al., 1986). It was later shown that a variety of
stimuli that mimic the effects of neuronal activity, such as bath
application of neurotransmitters or membrane depolarizing
levels of potassium chloride, also robustly induce c-fos tran-
scription in primary neuronal cultures and that c-fos transcription
also occurs in the intact brain in response to a wide variety of
physiological stimuli (e.g., novel, visual, and social experiences,
circadian entrainment, fear conditioning, and exposure to drugs
of abuse) (Anokhin et al., 1991; Dragunow and Robertson, 1987;
Hope et al., 1992; Morgan et al., 1987; Rusak et al., 1990).
Neuron
ReviewSubsequent studies revealed that c-fos is one of several
hundred genes that are regulated by neuronal activity as synap-
ses are forming and maturing (Altar et al., 2004; Hong et al., 2004;
Li et al., 2004; Nedivi et al., 1993; Park et al., 2006). Many of the
activity-regulated genes like c-fos encode transcription factors
that are believed to mediate the cellular response to synaptic
stimulation by activating target genes that play important roles
in cell survival, dendritic and axonal growth, synaptic develop-
ment, and neuronal plasticity. In addition, many of the genes
whose expression is directly regulated by neuronal activity en-
code proteins that act specifically at synapses to control various
aspects of synaptic development and function. These include
BDNF, a neurotrophin that regulates survival, dendritic growth,
and excitatory and inhibitory synaptic development; Arc, a cyto-
plasmic protein that controls glutamate receptor endocytosis;
Cpg15, a membrane-bound protein that regulates survival and
dendritic growth; and Homer1a, which controls the formation
of synaptic protein complexes, thus controlling synapse number
(Cantallops et al., 2000; Chowdhury et al., 2006; Kang and Schu-
man, 1995; Korte et al., 1995; McAllister et al., 1995, 1997; Nedivi
et al., 1998; Rial Verde et al., 2006; Sala et al., 2003). Because
activity-regulated transcripts play such crucial and broad roles
in neuronal development, considerable effort has gone into un-
derstanding the signaling mechanisms by which neurotransmit-
ter release at synapses induces gene expression in the nucleus.
Additional effort has been directed toward analyzing the function
of activity-regulated genes in synaptic development and testing
the hypothesis that these critical synaptic regulators, when
mutated, are the cause of a wide range of neurological disorders.
Rises in Levels of Intracellular Calcium:
The Route of Entry Matters
Like most excitable cells, neurons expend considerable energy
in maintaining low basal levels of intracellular calcium by pump-
ing calcium either into internal storage organelles or the extracel-
lular space. By maintaining low levels of calcium within the cell,
the neuron is able to respond rapidly and effectively to increases
in intracellular calcium concentration. There are multiple ways in
which cytoplasmic calcium levels can rapidly increase in the
postsynaptic neuron: calcium can be released from intracellular
stores maintained by the neuron, or extracellular calcium can en-
ter the cytoplasm through voltage-gated calcium channels or
either of two types of ligand-gated ion channels, the N-methyl-
D-aspartate type (NMDA) or a-amino-3-hydroxy-5-methyl-4-iso-
xazolepropionate type (AMPA) glutamate receptors (Berridge,
1998; Jonas and Burnashev, 1995). Interestingly, although
each of these routes of calcium entry lead to significant in-
creases in the concentration of intracellular calcium, depending
on the mode of entry, there can be quite different responses in
terms of gene induction (Bading et al., 1993; Ginty, 1997). For
example, brain-derived neurotrophic factor (BDNF) is highly
induced in excitatory neurons following calcium entry through
L-type voltage-sensitive calcium channels (VSCCs) but much
less effectively following calcium influx through NMDA receptors
or other VSCCs, such as N-type calcium channels (Ghosh et al.,
1994; Westenbroek et al., 1992). These and a variety of addi-
tional findings initially led to speculation that the route (i.e., the
specific channel) through which calcium enters the neuron iscritical for determining the pattern of gene induction. Recent
studies have identified a variety of features of calcium channels
that determine whether calcium influx through the channel will
trigger a gene expression response. These include channel
conductance properties, channel open times, subcellular locali-
zation of the channel, the ability of the channel to trigger an in-
crease in the calcium concentration within the nucleus, and the
association of the calcium channel with key signaling molecules
(see below).
L-type VSCCs were the first of the neuronal calcium channels
to be shown to be involved in the induction of activity-dependent
gene transcription. L-type VSCCs have several properties that
make them particularly well suited for conveying a calcium signal
from the site of entry at the plasma membrane to the site of gene
induction within the nucleus. For example, L-type VSCCs have
a relatively slow inactivation rate and a high single-channel
conductance for calcium, allowing these channels to flux the
large amounts of calcium into neurons that is required to elicit
a gene expression response (Gallin and Greenberg, 1995). In ad-
dition, L-type VSCCs are somatodendritically localized, enabling
them to elevate calcium levels within the cell soma in close prox-
imity to the nucleus, thus allowing efficient propagation of the
calcium signal to the nucleus or elevating calcium levels directly
within the nucleus (Catterall, 2000; Westenbroek et al., 1990).
Furthermore, a number of signaling proteins important for gene
induction associate with L-type VSCCs, including the protein ki-
nase A anchoring protein (AKAP79/150), the tyrosine kinase Src,
and the phosphatase calcineurin (Bence-Hanulec et al., 2000;
Gray et al., 1998; Oliveria et al., 2007). AKAP79/150 recruits
PKA to L-type VSCCs, leading to the phosphorylation of the
channel, increasing its ability to flux calcium. At the same time
AKAP79/150 recruits the phosphatase calcineurin to L-type
VSCCs. Calcineurin activation is required for the translocation
of the transcription factor NFATc4 to the nucleus and for NFATc4
activation as well as for the dephosphorylation and activation of
MEF2 family transcription factors (Chin et al., 1998; Graef et al.,
1999; Mao and Wiedmann, 1999). Additionally, it has been dem-
onstrated that the calcium-sensing protein calmodulin binds to
the intracellular domain of the L-type channel that, upon calcium
influx, activates Ras/MAP kinase signaling to initiate gene tran-
scription within the nucleus (Dolmetsch et al., 2001). Consistent
with these observations, pharmacological blockade of L-type
VSCCs as well as chelation of calcium in close proximity to the
plasma membrane inhibits immediate-early gene induction
(Murphy et al., 1991; Deisseroth et al., 1996).
Despite the obvious importance of calcium influx through
L-type VSCCs for the induction of gene transcription in response
to neuronal activity, calcium influx through other types of ion
channels—especially during early development—also plays an
important role in regulating gene expression. During early stages
of synaptogenesis, the EphB family of receptor tyrosine kinases
and their ligands the ephrins modulate NMDA receptor function
to drive gene expression within the nucleus (Takasu et al., 2002).
EphB receptors play important roles in synapse development
and function, and during development, contact between post-
synaptic EphB receptors and presynaptic ephrins may induce
the association of NMDA receptors with EphB receptors (Dalva
et al., 2000). Ephrin binding to EphBs also leads to the activationNeuron 59, September 25, 2008 ª2008 Elsevier Inc. 847
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phorylates the NR2B subunit of the NMDA receptor, allowing
for increased calcium influx through NMDA receptors upon
release of the neurotransmitter glutamate at the developing
synapse. While this calcium influx is sufficient to drive gene
expression, future experiments will be required to determine
the significance of these events during nervous system
development.
Nonetheless, these data suggest a possible role for NMDA
receptors in activity-mediated gene induction during develop-
ment, and there is mounting evidence to suggest that complexes
associated with NMDA receptors help mediate these transcrip-
tional responses. NMDA receptors are heteromeric ion channels
comprised of NR1 and NR2 subunits. Early in development,
NMDA receptors are primarily composed of NR1 and NR2B sub-
units before undergoing a developmental switch that results in
NR2B being replaced by NR2A (Carmignoto and Vicini, 1992).
Upon binding glutamate NR2B subunit-containing NMDA recep-
tors have longer durations of calcium influx than their NR2A-pos-
sessing counterparts, suggesting that NMDA receptors early in
development are better suited to regulate gene expression in
the nucleus. Consistent with this possibility, stimulation of
NMDA receptors in young neurons triggers robust phosphoryla-
tion and activation of the cyclic-AMP response element binding
protein, CREB, an important mediator of activity-dependent
transcription, whereas stimulation of older neurons only induces
the transient phosphorylation of CREB (Sala et al., 2000). Inter-
estingly, a CREB phosphatase, protein phosphatase 1 (PP1),
has been shown to physically associate with NMDA receptors
in older neurons, possibly explaining why CREB phosphorylation
and activation are so transient later in development (Westphal
et al., 1999).
In addition to PP1, NMDA receptors interact directly or indi-
rectly with a large number of signaling molecules (e.g., calmod-
ulin, CaMKII, calcineurin, Tiam1, and proteins involved in Ras/
MAP kinase signaling, including H-Ras, c-RAF1, Mek1 and -2,
and Erk1 and -2), each of which has been implicated in the
regulation of activity-dependent transcription (Husi et al., 2000;
Tolias et al., 2005). Calmodulin, upon binding to calcium, un-
dergoes a conformational switch enabling calmodulin to bind
to and activate a number of effector proteins in the nucleus
and the cytoplasm, including CaMKII and the phosphatase cal-
cineurin (Chin and Means, 2000). Calcineurin dephosphorylates
MEF2 transcription factors, a necessary step for their activation,
while CaMKII phosphorylates and activates a number of activity-
dependent transcription factors, including CREB and NeuroD. In
addition to activating transcription factors directly, CaMKII phos-
phorylates the NMDA receptor-associated protein Tiam1, a gua-
nine nucleotide exchange factor (GEF) that activates the small
GTPase Rac1, a regulator of the actin cytoskeleton. Calcium
influx through NMDA receptors also activates a number of other
Rac GEFs, including betaPIX and Kalirin-7 (Xie et al., 2007;
Saneyoshi et al., 2008). Actin in turn may regulate the serum
response factor SRF by controlling the nuclear localization of
its cofactor MAL (Vartiainen et al., 2007). SRF and CREB are
also regulated by the Ras/MAP kinase pathway, which triggers
RSK/MSK activation, leading to SRF phosphorylation at serine-
103 and CREB phosphorylation at serine-133 (Heidenreich848 Neuron 59, September 25, 2008 ª2008 Elsevier Inc.et al., 1999). Together these events promote activity-dependent
gene activation and suggest an important role for NMDA recep-
tors in regulating signaling to the nucleus to affect synapse
development and maturation.
In addition to NMDA receptors, AMPA-type glutamate recep-
tors (GluRs) are also able under some circumstances to activate
gene transcription. AMPA receptors are tetramers comprised of
various combinations of GluR1–4 subunits and mediate the ma-
jority of excitatory synaptic transmission in the central nervous
system (CNS) (Derkach et al., 2007). The majority of AMPA
receptors are not permeable to calcium. This is due to the fact
that these channels contain GluR2 subunits that as a conse-
quence of RNA editing have a positively charged arginine in
the AMPA receptor’s channel pore that renders the channel im-
permeable to calcium. However, calcium-impermeable AMPA
receptors are able to promote activity-dependent transcription
under conditions where glutamate binding to the AMPA receptor
depolarizes the plasma membrane sufficiently to trigger opening
of the L-VSCCs. In addition, calcium-permeable AMPA recep-
tors (those lacking GluR2) can drive gene expression directly.
In response to calcium influx through GluR2-lacking AMPA
receptors, calcium/calmodulin promotes the activation of Ras-
GRF (guanine nucleotide-releasing factor) proteins, which once
activated stimulate Ras-ERK signaling pathways, which in turn
trigger the phosphorylation of CREB at serine-133 and induce
activity-dependent transcription (Tian and Feig, 2006). Interest-
ingly, during early development, neurons preferentially express
GluR2-lacking AMPA receptors (calcium permeable), while in
the mature brain, GluR2-containing AMPA receptors (calcium
impermeable) predominate, suggesting that during brain devel-
opment different activity-dependent transcriptional programs
may be induced than in the mature nervous system (Kumar
et al., 2002).
The activation of glutamate receptors and L-type VSCCs leads
to local increases in calcium near the mouth of these channels
but can also trigger substantial increases in nuclear calcium. It
is now appreciated that an elevation of calcium concentration
within the nucleus is required in some cases for the induction
of the activity-dependent gene expression program. For exam-
ple, a rise in nuclear calcium is required for CREB-mediated,
but not SRF-dependent, transcription, and blocking the activ-
ity-dependent elevation in nuclear calcium results in decreased
neuronal survival and defective memory consolidation (Chawla
et al., 1998; Hardingham et al., 1997; Limback-Stokin et al.,
2004; Papadia et al., 2005).
How Calcium Signals within the Nucleus
As discussed above, calcium enters neurons through both so-
matodendritically and synaptically localized ion channels. Under
circumstances where the calcium signal is propagated to the
nucleus, it can trigger the activation of an intricate program of
activity-dependent gene expression (Figure 1). Over 300 genes
have been shown to be turned on and off again in response to
neuronal activity, and remarkably, each gene has a unique time
course and magnitude of induction (Lin et al., 2008). Elucidation
of the mechanisms that keep these genes off until the right time
and place and then allow their transient activation in response to
neuronal activity has primarily come from the study of two
Neuron
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activated by extracellular stimuli in a wide variety of tissues and
cell types, Bdnf transcription is preferentially activated in re-
sponse to neuronal activity and thus is induced primarily in neu-
rons (West et al., 2001).
Like many activity-regulated genes,Bdnf has a complex geno-
mic organization allowing for precise temporal, spatial, and stim-
ulus-specific regulation of its transcription (Figure 2). The Bdnf
gene is composed of at least eight discrete promoters that initi-
ate the transcription of multiple distinct Bdnf mRNAs, each of
which contains an alternative 50 exon spliced to a common 30
coding exon that employs either of two polyadenylation sites.
The alternative promoters together with alternative splicing and
polyadenylation result in the production of at least 18 distinct
Bdnf mRNAs, each of which encodes an identical protein (Aid
et al., 2007). Why the Bdnf genes give rise to so many mRNA
transcripts, all of which encode an identical protein, is not yet
fully appreciated, but it suggests that this organization may allow
for tight temporal and spatial control of Bdnf transcription. Addi-
tionally, as these different mRNA species contain unique 30 and
50 untranslated regions (UTRs), it may be that sequences con-
tained within the UTRs target differentBdnf transcripts to distinct
subcellular locations where they may exert different effects on
nervous system development. Consistent with this possibility,
a recent study found that a sequence contained within the longer
30 UTR targetsBdnfmRNA to distal dendrites. Furthermore, mice
that lack the long 30 UTR have impaired dendritic spine morpho-
genesis as well as defects in synaptic plasticity (An et al., 2008).
Interestingly, of the 18 mRNA transcripts described above, those
that are transcribed from promoters I and IV are the most respon-
sive to neuronal activity, raising the possibility that activity may
regulate some functions of BDNF but not others (see below).
Unlike genes such as c-fos that are induced throughout the
body in response to a wide variety of extracellular stimuli, Bdnf
transcription appears to be largely restricted to the nervous
system. This neural specificity of Bdnf expression may be ac-
complished at least in part through the action of the RE1 silenc-
ing transcription factor (REST) repressor complex (Chong et al.,
1995; Schoenherr and Anderson, 1995; Lunyak et al., 2004). As
its name implies, REST binds to neuron restrictive silencer
elements (NRSEs or RE1s) and recruits transcriptional repressor
complexes, thus silencing the expression of nervous-system-
specific genes in nonneuronal cells. Bdnf contains an RE1 be-
tween its first and second exons, and recent evidence suggests
that REST binding to this site represses Bdnf transcription in
nonneuronal cells (Abuhatzira et al., 2007).
Of the eight Bdnf promoters, promoters I and IV are the most
responsive to neuronal activity both in vitro (e.g., in cultured neu-
rons in response to membrane depolarization and glutamate
release at synapses) and in vivo (e.g., in mice in response to
kainate-induced seizure, fear conditioning, and visual stimula-
tion), and most efforts to characterize the mechanisms by which
neuronal activity induces Bdnf transcription have focused on
Bdnf promoter IV (referred to as promoter III in earlier literature)
(Tao et al., 1998; Timmusk et al., 1993; Rattiner et al., 2004). Initial
studies of Bdnf transcription employed promoter deletion analy-
sis, DNA-binding studies, biochemistry, and yeast one-hybrid
cloning approaches to identify first the DNA regulatorysequences and then the transcription factors that mediate cal-
cium-dependent Bdnf promoter IV-driven transcription (Chen
et al., 2003b; Tao et al., 1998, 2002). More recently, chromatin
immunoprecipitation and bioinformatics studies have helped to
expand our understanding of the regulators of activity-depen-
dent Bdnf transcription (Chen et al., 2003b; Y. Lin, S. Flavell,
and M.E.G., unpublished data). These various approaches have
led to the identification of at least six transcription factors
(CREB, CaRF, USF, MeCP2, MEF2, and NPAS4) that contribute
to activity-dependent Bdnf transcription (Chen et al., 2003a;
Flavell et al., 2006; Lin et al., 2008) (Figure 3). Prior to neurotrans-
mitter release at synapses, the BDNF promoter is effectively re-
pressed. In this state, Bdnf promoter IV is bound by at least
four of these transcription factors (CREB, USF, MeCP2, and
MEF2). However, despite the presence of multiple transcription
factors at BDNF promoter IV, prior to neurotransmitter release
and calcium influx into the postsynaptic neuron, the chromatin
surrounding the initiation site of Bdnf transcription synthesis is
bound by histones that are methylated, and the chromatin is con-
densed, a state that is correlated with gene repression (Chen
et al., 2003a; Martinowich et al., 2003). This likely reflects the abil-
ity of transcription factors such as MEF2 to recruit histone deace-
tylases (HDACs), which function to remove activating acetyl
groups from histones and histone methyltransferases, which re-
place the removed acetyl groups with deactivating methyl
groups, thus favoring a silenced or repressed state of transcrip-
tion. In nonneuronal cells, in the absence of calcium signaling
to the nucleus, MEF2 interacts with the protein CABIN1, and
through this interaction recruits HDACs 1 and 2 as well as the
methyltransferase SUV39H1 to repress transcription (Jang
et al., 2007; Youn and Liu, 2000; Youn et al., 1999). Although
a similar function for CABIN1 has not yet been demonstrated in
neurons in the absence of synaptic activity, MEF2 represses tran-
scription in neurons through an interaction with HDACs. Likewise,
MeCP2 interacts with the Sin3/HDAC repressor complex, which
may further modify the chromatin structure ofBdnfpromoter IV to
inhibit transcription (Nan et al., 1998).
Upon neurotransmitter release at a synapse and the activation
of calcium signaling to the nucleus, the transcriptional complex
that previously served to repress Bdnf promoter IV-dependent
transcription is converted to an activating complex and Bdnf
transcription ensues. The activation of Bdnf occurs within sev-
eral minutes of neurotransmitter release, and Bdnf mRNA levels
peak 6–8 hr following neuronal stimulation (Hong et al., 2008).
For full activation of Bdnf transcription to occur, the histones
must be demethylated and acetylated. Although it is not fully ap-
preciated how neuronal activity regulates the demethylation of
histones at Bdnf promoter IV, it has been suggested that the his-
tone demethylase JARID1C/SMCX can demethylate histones
bound to the Bdnf promoter (Tahiliani et al., 2007). In addition
to promoting histone demethylation, neuronal activity also
serves to increase histone acetylation atBdnf promoter IV (Tsan-
kova et al., 2004). First, rises in nuclear calcium concentration
promote the dissociation of MEF2 from HDACs. This appears
to involve the dephosphorylation of MEF2 by calcineurin at ser-
ine-408 and the phosphorylation of HDAC4 by CaMKII (Flavell
et al., 2006; Zhang et al., 2007). Around the same time, CREB be-
comes newly phosphorylated at serine-133 (5 min afterNeuron 59, September 25, 2008 ª2008 Elsevier Inc. 849
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Calcium influx through NMDA receptors, AMPA receptors, or L-type VSCCs triggers the activation of a number of signaling molecules that ultimately lead to the
expression of new gene products. The signaling cascades induced by calcium influx include the Ras/MAPK pathway, the calcium/calmodulin-dependent protein
kinases, the phosphatase calcineurin, and Rac GTPases. These pathways in turn modify the activity of a large number of transcription factors that activate the
850 Neuron 59, September 25, 2008 ª2008 Elsevier Inc.
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with its coactivator, CREB-binding protein (CBP) (Chrivia et al.,
1993; Dash et al., 1991; Gonzalez and Montminy, 1989; Sheng
et al., 1991). CBP possesses intrinsic histone acetyl transferase
(HAT) activity, and likely at least in part through the recruitment of
this HAT activity, neuronal activity triggers the acetylation of his-
tones and the recruitment of key components of the RNA poly-
merase II complex (Bannister and Kouzarides, 1996; Kwok
et al., 1994). RNA polymerase II is also likely recruited to Bdnf
promoter IV in response to calcium influx through the actions
of the CREB coactivators, the transducers of regulated CREB
activity (TORCs) (Conkright et al., 2003; Iourgenko et al., 2003).
Calcium influx induces the dephosphorylation of the TORCs by
calcineurin, triggering the translocation of the TORCs into the nu-
cleus (Bittinger et al., 2004). In the nucleus, the TORCs promote
the transcription of CREB target genes by recruiting TAFII130,
a key component of the RNA polymerase holoenzyme.
Following these initial events, a nuclear form of CaMKII ap-
pears to phosphorylate MeCP2 at serine-421 15–30 min after
neurotransmitter release at excitatory synapses (Zhou et al.,
2006). While it is not yet clear how phosphorylation of MeCP2
at serine-421 contributes to the activation of BDNF promoter
IV transcription, the kinetics of MeCP2 phosphorylation are de-
layed relative to CREB serine-133 phosphorylation and MEF2
dephosphorylation. The phosphorylation of MeCP2 at serine-
421 closely parallels the activation of Bdnf transcription, sug-
gesting that MeCP2 serine-421 phosphorylation may be a final
step required for Bdnf promoter IV transcriptional activation.
Consistent with this possibility, the mutation of MeCP2 serine-
421 to an alanine partially blocks the neuronal activity-depen-
dent activation of Bdnf promoter IV (Zhou et al., 2006).
The observation that MeCP2 is localized to discrete regions of
the nucleus containing heterochromatin raises the provocative
possibility that MeCP2 may interact with the locus control region
(LCR) of DNA (Nan et al., 1996). Locus control regions are tran-
scriptional regulatory sequences that can be present at great
distances from the gene that the LCR regulates (Li et al., 2002).
LCRs can affect gene expression by a process of DNA looping
that brings factors bound to the LCR and the gene promoter in
close proximity to one another. It may be that in the unphospory-
lated state, MeCP2 functions to dock Bdnf promoter IV to a
repressor locus that ensures that Bdnf promoter IV is kept off
even though it is in a state ready for transcriptional activation
(i.e., transcription factors are already bound to the promoter). If
so, then only upon phosphorylation of MeCP2 at serine-421
would Bdnf promoter IV be released from this repressor locus,
allowing for robust transcription.
Recent evidence suggests that MeCP2, in addition to func-
tioning as a repressor of gene expression, may work as an acti-
vator in a complex with CREB (Chahrour et al., 2008). It is possi-
ble that MeCP2, CREB, and MEF2 act together to recruit CBP to
Bdnf promoter IV once CREB and MeCP2 are phosphorylated at
serine-133 and serine-421, respectively, and MEF2 is dephos-
phorylated at serine-408. The binding of CBP to serine-133
phosphorylated CREB may then be the critical step that initiatestranscription fromBdnf promoter IV. In addition to possessing in-
trinsic HAT activity, CBP activates transcription by recruiting and
stabilizing RNA polymerase II to promoters. Furthermore, CBP is
itself phosphorylated on serine-301 by CaMKIV in response to
neuronal stimulation, and this phosphorylation activates CBP
transcriptional activity (Impey et al., 2002). These observations
further suggest a critical role for CBP recruitment in the activa-
tion of Bdnf promoter IV-dependent transcription.
Once Bdnf promoter IV transcription is activated, there ap-
pears to be mechanisms in place that function to sustain Bdnf
transcription when necessary and other mechanisms that ensure
thatBdnf transcription is shut off at the proper time. Concomitant
with Bdnf promoter IV activation, a large number of other activ-
ity-regulated genes are also induced. One of these activity-reg-
ulated genes encodes a transcription factor, NPAS4, that binds
to Bdnf promoter IV 30 min after the initial stimulating event
and appears to sustain the amount of Bdnf mRNA that is tran-
scribed inasmuch as disruption of NPAS4 function leads to an at-
tenuation of Bdnf promoter IV transcription (Ooe et al., 2004; Lin
et al., 2008). Given recent evidence that Npas4 functions to pro-
mote inhibitory synapse formation/function, it is possible that
sustaining Bdnf transcription may prove to be important for es-
tablishing the proper balance between excitation and inhibition
during nervous system development.
Within several hours of its activation, Bdnf promoter IV tran-
scription returns to the low level that was present in the neuron
prior to neurotransmitter release at synapses. Although less is
known regarding the mechanism by which Bdnf transcription is
attenuated, this shut off ofBdnf transcription is likely to be impor-
tant for maintaining the precise levels of BDNF that are required
for normal development. The shut off ofBdnf transcription is par-
alleled temporally by the dephosphorylation of MeCP2 and CREB
at serine-421 and serine-133, respectively, by phosphatases, in-
cluding the CREB phosphatase PP1. In addition, MEF2 becomes
newly phosphorylated at serine-408, possibly by CDK5 (Gong
et al., 2003). Other events that may contribute to the shut off of
Bdnf promoter IV transcription include the phosphorylation of
CREB at serines-142 and -143 (Kornhauser et al., 2002; Gau
Figure 2. Schematic Representation of the Bdnf Gene
Bdnf consists of at least eight distinct promoters (I–VIII) that initiate the tran-
scription of multiple distinct Bdnf mRNAs, each of which contains an alterna-
tive 50 exon spliced to a common coding exon (exon IX) that employs either of
two polyadenylation sites (pA). As many of these exons have only been re-
cently identified, we have included the old nomenclature for the Bdnf exons
in gray above for clarity. For example, the current exon IV was previously re-
ferred to as exon III.transcription of several hundred genes in response to calcium influx. These calcium-responsive genes affect a variety of biological processes, including neuronal
survival and dendritogenesis, as well as synaptic development, maturation, and plasticity. This figure is adapted from Zieg et al. (2008).Neuron 59, September 25, 2008 ª2008 Elsevier Inc. 851
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time course relative to the phosphorylation of CREB at serine-133.
Phosphorylation of CREB at serines-142 and -143 inhibits CREB
binding to CBP, and, consistent with the idea that phosphorylation
of these sites could inhibit CREB activity, mutation of serine-142
to the nonphosphorylateable alanine leads to the enhanced acti-
vation of CREB target genes. These results raise the possibility
that phosphorylation of CREB on serines-142 and -143 may be
part of the mechanism for shutting off Bdnf transcription.
It is clear from the work described above that there is a large
amount now known about the mechanisms by which neuronal
activity regulates Bdnf transcription. However, despite the prog-
ress in identifying the repressor and activator complexes that
control activity-dependent Bdnf promoter IV transcription,
much remains to be determined. We still do not understand
the roles of CaRF or USF in regulating transcription from the
Bdnf promoter, and there are a number of calcium-dependent
modifications that occur to the transcription factors that regulate
Bdnf to which a function and/or mechanism have yet to be as-
cribed (e.g., the acetylation/sumoylation of MEF2, the phosphor-
ylation of MeCP2, and the phosphorylation of CREB at serines-
142 and -143).
Furthermore, much of the work described above has been
carried out in cultured neurons, and additional experiments will
be required to determine the role of the various calcium-regulated
transcription factors in the control of Bdnf transcription in re-
sponse to physiological stimuli in vivo. To date, experiments
that have been performed in vivo have yielded results that are sim-
ilar to those using cultured neurons, suggesting that the observa-
tions described above are likely to hold true under more physio-
logical conditions. For example, Bdnf promoter I and IV are the
most highly induced of the eight Bdnf promoters in response to
physiological in vivo stimuli (e.g., fear conditioning and visual
stimulation) (Rattiner et al., 2004; Hong et al., 2008). In addition,
enhancing or blocking the function of transcription factors that
regulate the transcription of Bdnf promoter IV in vitro has been
shown to have similar effects in vitro and in vivo. This has been
Figure 3. Schematic Representation ofBdnfPromoter
IV-Bound Transcription Factor Complexes in the
Absence and Presence of Calcium Influx
In the absence of calcium influx, Bdnf promoter IV is bound by
a number of transcription factors (CREB, USF1/2, CaRF,
MEF2, and MeCP2) that function to recruit repressor com-
plexes, including HDACs and methyltransferases. Upon cal-
cium influx, these transcription factors are modified, as is
the state of the chromatin surrounding Bdnf exon IV. These
modifications include the phosphorylation of MeCP2 and
CREB and the dephosphorylation of MEF2. NPAS4 is also
newly transcribed and translated and binds to the proximal
promoter of BDNF exon IV. These modifications result in the
recruitment of the transcriptional coactivator CBP and the
RNA polymerase II holoenzyme, which in turn leads to
the transcription of BDNF exon IV.
best demonstrated for CREB, where expression of
a constitutively active form of CREB (CREB-VP-16)
in mice drives the transcription of Bdnf (Barco
et al., 2005). Conversely, a subtle mutation of the
CREB-binding site in Bdnf promoter IV in mice sig-
nificantly blocks the induction of Bdnf by physiological stimuli
such as visual experience (Hong et al., 2008). These results sug-
gest that the conclusions drawn from in vitro studies of the mech-
anisms of activity-dependent gene regulation are likely to be
highly relevant in vivo.
Perhaps the most significant remaining question is why there
are so many factors that contribute to the regulation of the tran-
scription of this one gene in response to calcium influx into neu-
rons. There are a number of possible reasons why the nervous
system has evolved such intricate mechanisms to regulate
Bdnf transcription. The most obvious possibility is that this al-
lows for a precise temporal and scaled response ensuring that
exactly the right amount of BDNF is expressed at the appropriate
time and place. By activating or not activating a given transcrip-
tion factor, the neuron may be able to dial up or down the amount
of Bdnf mRNA that is transcribed. For example, the presence of
multiple transcription factors may allow the neuron to respond
differently to different frequencies of stimulation and levels of cy-
toplasmic and nuclear calcium. It is also possible that different
cell types express unique combinations of the transcription fac-
tors that regulate Bdnf transcription, thus facilitating differential
BDNF responses in different cell types. Finally, the large number
of transcription factors that regulate Bdnf transcription may
simply reflect the fact that Bdnf transcription is complex—that
in the absence of activity Bdnf is repressed and that following
stimulation Bdnf is turned on transiently before it is again shut
off. It may be that a large number of factors are required to
effectively accomplish each of these tasks.
Other Activity-Regulated Genes in Nervous
System Development
Although we have focused this review on the regulation of Bdnf
promoter IV transcription, the mechanisms that controlBdnf pro-
moter IV transcription are likely to also be relevant to the regula-
tion of many other activity-regulated genes. As discussed above,
several hundred genes have been identified whose transcription
is regulated by neuronal activity. Genome-wide analyses of
852 Neuron 59, September 25, 2008 ª2008 Elsevier Inc.
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MEF2, and Npas4 are likely to control the activity-dependent
transcription of a large number of activity-regulated genes in ad-
dition to Bdnf (Flavell et al., 2006; Impey et al., 2004). However,
these three transcription factors by themselves do not account
for the entirety of activity-dependent gene transcription. In fact,
there are a large number of additional transcription factors that
mediate neuronal-activity-driven transcription, including SRF,
ELK, NFAT, NFkB, DREAM, NeuroD, SP4, and CREST, and for
each of these factors the mechanism of activation in response
to calcium influx appears to be distinct (Aizawa et al., 2004; Car-
rion et al., 1999; Gaudilliere et al., 2004; Graef et al., 1999; Meffert
et al., 2003; Ramos et al., 2007; Shaw et al., 1989; Treisman,
1987). For instance, SRF and NeuroD are phosphorylated and ac-
tivated in the nucleus by the calcium-activated RSK/MSK and
CaMKII kinases, respectively (Gaudilliere et al., 2004; Rivera
et al., 1993). On the other hand, NFAT and NFkB are localized
to the cytoplasm prior to stimulation. Calcium influx into the neu-
ron triggers the dephosphorylation of NFAT by calcineurin and
the phosphorylation of NF-kB by CaMKII, which in turn lead to
the translocation of NFAT and NF-kB to the nucleus where they
activate transcription (Graef et al., 1999; Meffert et al., 2003).
The mechanism of downstream regulatory element-antagonist
modulator (DREAM) activation is also distinct. Prior to neuronal
stimulation, DREAM binds to the promoters of its target genes
and represses their transcription. Upon neurotransmitter release,
DREAM binds directly to calcium ions that enter the nucleus, and
upon binding to calcium, DREAM is released from the promoters
of its target genes, thus relieving transcriptional repression and
allowing transcription of these genes (Carrion et al., 1999).
Interestingly, these activity-regulated transcription factors
control the expression of overlapping but distinct subsets of
activity-regulated genes, suggesting a mixing and matching of
transcription factors to achieve the precise temporal, spatial,
and stimulus-specific control as well as the appropriate magni-
tude of induction for each of the activity-regulated genes that
is needed for proper synaptic development. The large number
of genes that are regulated by neuronal activity as well as the
precise control of the expression of these genes in response to
neurotransmitter release suggest that the program of activity-
dependent gene expression is likely to play an important role in
nervous system function. Consistent with this hypothesis, com-
ponents of the activity-dependent transcription program have
been shown to play key roles in many different aspects of ner-
vous system development, including neuronal survival, dendritic
growth, synapse formation, synapse refinement, and synaptic
plasticity. As the role of activity-dependent transcription in neu-
ronal survival has been reviewed (Mattson and Meffert, 2006;
Bonni and Greenberg, 1997), we will focus here on how activ-
ity-dependent transcription regulates synapse development
and function.
Activity-Dependent Gene Regulation and Biology
Dendritic Development
In the CNS, the vast majority of synapses form onto the dendrites
of neurons. As the dendritic structure of the neuron is a crucial
determinant of the processing of synaptic inputs, one way in
which neuronal activity regulates synaptic processing is by alter-ing the length or complexity of dendrites. Dendritic growth is
a highly dynamic process that is tightly regulated by synaptic
activity so that appropriate connections are formed and main-
tained. Sensory blockade by monocular deprivation significantly
alters dendritic development in both the lateral geniculate
nucleus and the visual cortex (Coleman and Riesen, 1968; Wie-
sel and Hubel, 1963). These observations suggested that neuro-
nal activity plays a critical role in dendritic development and have
been extended by a large number of more recent studies (Chen
and Ghosh, 2005; Cline, 2001; Hooks and Chen, 2007). For
instance, blocking neuronal activity in vivo by infusion of the so-
dium channel blocker tetrodotoxin (TTX) results in reduced den-
dritic branching of CA1 hippocampal pyramidal neurons (Groc
et al., 2002). Conversely, exposure of rodents to an enriched
environment leads to an increase in dendritic growth and an
elaboration of dendritic arborization (Faherty et al., 2003). Like-
wise, in Xenopus tectum, light-induced visual activity increases
the growth of new dendritic branches and concurrently stabilizes
existing branches (Sin et al., 2002). Taken together, these results
and others suggest a broad role for activity in promoting
dendritic growth and maintenance.
Activity-dependent gene transcription plays a key role in
mediating the effect of neuronal activity on dendritic growth.
Disrupting CREB function interferes with the ability of neuronal
activity to influence dendritic growth (Redmond et al., 2002;
Wayman et al., 2006). Similarly, blocking NeuroD function by
RNAi or preventing the activity-dependent phosphorylation of
NeuroD on serine-336 is sufficient to block calcium-mediated
dendritic growth (Gaudilliere et al., 2004). Another activity-regu-
lated transcription factor that plays a role in regulating dendritic
growth is the calcium-responsive transactivator, CREST. Layer V
cortical and CA3 pyramidal neurons of CREST knockout mice
have significantly fewer dendrites and are not responsive to
membrane-depolarizing stimuli that induce the growth of den-
drites in wild-type neurons (Aizawa et al., 2004).
In addition to the effects on dendritic growth of the activity-reg-
ulated transcription factors described above, a number of genes
whose transcription is regulated by neuronal activity also play an
important role in controlling dendritic growth. A screen for poten-
tial CREB target genes identified the micro RNA miRNA132 as
a CREB target (Impey et al., 2004). Overexpression of miRNA132
increases, while blocking miRNA132 function decreases, neurite
growth (Vo et al., 2005). miRNA132 controls dendritic growth by
regulating the translation of p250GAP, a protein that affects actin
cytoskeletal dynamics (Wayman et al., 2008a). Similarly, overex-
pression of candidate plasticity gene 15 (cpg15) enhances den-
dritic outgrowth as well as axonal elaboration (Cantallops et al.,
2000; Nedivi et al., 1998). Together, these results suggest a broad
role for activity-dependent gene induction in regulating synaptic-
activity-driven dendritic remodeling.
Synapse Elimination
Often during the development of neuronal circuits, a larger num-
ber of synapses are formed than are ultimately present within the
mature neural circuit, and these excess synapses are eliminated
in a manner that is dependent upon sensory-experience-driven
synaptic activity (Katz and Shatz, 1996; Sanes and Lichtman,
1999). The role of synaptic activity in synapse elimination has
been particularly well characterized at the neuromuscular
Neuron 59, September 25, 2008 ª2008 Elsevier Inc. 853
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by multiple motor neuron axons. However, during early postnatal
development, synapse elimination occurs until the muscle fiber
is innervated by a single motor neuron axon. This elimination
occurs by a process where a single input gradually becomes
stronger, and the other inputs become weaker before being elim-
inated (Colman et al., 1997). Blocking synaptic activity by inhib-
iting neurotransmitter release prevents synapse elimination at
the NMJ, and as a result, muscle fibers remain multiply inner-
vated. A similar process of synapse elimination occurs in the
CNS (e.g., the retinogeniculate synapse, the synapse made by
retinal ganglion neurons onto thalamic neurons, and the climbing
fiber/Purkinje cell synapse in the cerebellum) (Chen and Regehr,
2000; Nishiyama and Linden, 2004). These results suggest
a broad and important role for neuronal activity in refining synap-
tic connectivity so that appropriate synaptic connections are
maintained and inappropriate synapses are eliminated.
It has recently been found that several of the components of
the activity-dependent transcription network control synapse
number and thus could be regulators of the process of synapse
elimination. Interfering with MEF2 function results in an increase,
while overexpression of MEF2 results in a decrease, in the num-
ber of excitatory synapses that form on hippocampal neurons
(Barbosa et al., 2008; Flavell et al., 2006). The ability of MEF2
to restrict synapse number is dependent on calcium and calci-
neurin and the ability of MEF2 to mediate activity-dependent
transcription, suggesting that MEF2 target genes are likely to
play important roles in the regulation of synapse number. Hom-
er1a and Arc are activity-regulated MEF2 target genes that may
mediate MEF2’s effect on synapse number. Induction of Hom-
er1a interferes with the assembly of synaptic complexes, thus
serving to reduce synapse number, while increasing Arc levels
leads to the internalization of AMPA receptors at synapses,
thus weakening the synapse and rendering it more prone to
elimination (Chowdhury et al., 2006; Rial Verde et al., 2006;
Sala et al., 2003).
Another activity-regulated gene that functions to restrict syn-
apse number is the serum-inducible kinase (SNK). Once SNK
expression is induced by synaptic activity, SNK phosphorylates
SPAR, a postsynaptic scaffolding molecule that functions to
promote synapse growth. However, following phosphorylation
by SNK, SPAR is rapidly degraded by the ubiquitin-proteasome
complex, resulting in a destabilization of synapses (Pak and
Sheng, 2003). Thus, activity-dependent SNK induction leads to
SPAR degradation, resulting in a decrease in synapse number.
Whether SNK and/or MEF2 and its target genes (homer1A and
Arc and others) play a direct role in developmental synapse elim-
ination in vivo and/or are involved in homeostatic control of
synapse number in response to excess excitation within a neural
circuit remains to be determined.
Excitatory/Inhibitory Balance
The proper balance of excitatory and inhibitory synaptic input is
crucial for processing sensory information as well as for higher
cognitive functions, and an increasing number of human neuro-
logical disorders are characterized by imbalances in excitatory
and inhibitory synaptic strength. Thus, there is considerable in-
terest in defining the mechanism by which neuronal activity reg-
ulates inhibitory synapse development and maturation (Cline,
854 Neuron 59, September 25, 2008 ª2008 Elsevier Inc.2005). Several recent studies have revealed that, in addition to
the ability to regulate the number of excitatory synapses, com-
ponents of the activity-dependent gene network also appear to
control the development and/or maintenance of inhibitory syn-
apses. Recent work identified a transcription factor, NPAS4,
that may control the balance between synaptic excitation and
inhibition within the CNS (Lin et al., 2008).
NPAS4 is a bHLH-PAS domain transcription factor whose
transcription is rapidly and transiently induced following calcium
influx into neurons. NPAS4 controls the number of inhibitory
synapses that form on excitatory neurons. The inhibition of
NPAS4 expression leads to a reduction, while overexpression
of NPAS4 leads to an increase, in the number of inhibitory synap-
ses that form on excitatory neurons. The acute deletion of
NPAS4 in hippocampal neurons within an intact neural circuit
in slice culture results in a significant reduction in mEPSC fre-
quency. This suggests that NPAS4 also controls excitatory syn-
aptic function, possibly as an indirect consequence of the effect
of loss of NPAS4 on inhibitory synapse number. These results in-
dicate that NPAS4 functions to increase synaptic inhibition and
decrease excitation, suggesting that NPAS4 is critical for main-
taining an appropriate balance of excitation and inhibition. In
addition to NPAS4, MEF2 may also play a role in the control of
excitatory/inhibitory balance through its ability to regulate
excitatory synapse number.
The balance between synaptic excitation and inhibition can be
altered by changing the strength as well as the number of excit-
atory and/or inhibitory synapses. Recently, the activity-regulated
transcriptional regulator MeCP2 has been shown to specifically
control the strength of excitatory synaptic connections (Dani
et al., 2005). Layer 5 cortical pyramidal neurons from MeCP2
knockout mice have significantly reduced spontaneous synaptic
activity due to a reduction in mEPSC amplitude. However, there
is no corresponding change in mIPSC amplitude in these mice,
suggesting that the alteration in excitability in MeCP2 knockout
mice is due to a change in the balance of excitatory and inhibitory
synaptic strength.
It is possible that the effects of NPAS4, MEF2, and MeCP2
on the balance between neuronal excitation and inhibition may
be explained at least in part by the ability of these factors to
regulate Bdnf promoter IV transcription. A recent study provides
some support for the idea that activity-dependent transcription
of Bdnf controls excitatory/inhibitory balance (Hong et al.,
2008). Mice were generated in which a subtle change was intro-
duced within the CREB-binding site ofBdnf promoter IV that pre-
cludes CREB binding. These knockin mice express similar levels
of Bdnf in the absence of stimulation but have significantly re-
duced levels of Bdnf promoter IV-dependent mRNA transcripts
following synaptic stimulation. Notably, in these knockin mice,
significantly fewer inhibitory synapses form on excitatory neu-
rons, suggesting that activity-dependent Bdnf transcription
plays a key role in regulating the number of inhibitory synapses.
Synaptic Plasticity
Sensory experience also affects neuronal connectivity within the
adult brain, and there is evidence that such neuronal plasticity is
mediated at least in part by the activity-regulated gene program.
This is true in paradigms of associative learning such as when an
electrical shock to the foot of an animal is delivered shortly after
Neuron
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this paired stimulus, animals learn that the auditory stimulus is
linked to the shock and exhibit a fear response when presented
with the auditory stimulus even in the absence of electrical
shock. This learning is accomplished by altering the strength of
synaptic connections within the dorsolateral nucleus of the
amygdala, which receive direct input from the auditory system
and are required for this type of associative learning. The neu-
rons of the dorsolateral nucleus significantly increase their firing
rate in response to the auditory stimulus once associative fear
conditioning has occurred (Maren and Quirk, 2004). These
changes in firing rate share many similarities with long-term po-
tentiation (LTP), an activity-dependent model for synaptic
strengthening, which is characterized by the insertion of AMPA
receptors into the postsynaptic membrane and the formation
of new synapses (Engert and Bonhoeffer, 1999; Malinow and
Malenka, 2002). Both associative learning and long-lasting forms
of LTP are correlated with, and have been shown to be depen-
dent upon, activity-dependent gene transcription.
The initial observation that activity-dependent transcription is
required for associative learning was made by Kandel and col-
leagues in the snail Aplysia californica. Aplysia undergo a form
of associative learning called sensitization in which the repeated
electrical stimulation of the snail’s tail triggers a defensive gill-
withdrawal response (Kandel, 2001). The Aplysia homolog of
CREB, CREB-1, is induced in sensory neurons following electri-
cal stimulation, and the inhibition of CREB-1 function interferes
with the strengthening of sensory neuron connections required
for sensitization (Dash et al., 1990; Kaang et al., 1993). These ex-
periments suggest that activity-dependent gene regulation
might be relevant to synaptic plasticity and learning. Experi-
ments in mammals have provided support for this possibility.
Targeted deletion of CREB in mice results in a defect in LTP
induction at Schaffer collateral-CA1 synapses in the hippocam-
pus, while regulated expression of a constitutively active form of
CREB (CREB-VP16) results in enhanced LTP (Bourtchuladze
et al., 1994; Barco et al., 2002). A stimulation paradigm that in
Figure 4. Mutation of Components of the Activity-
Dependent Gene Expression Program Results
in Human Cognitive Disorders
Mutation of a number of molecules that regulate Bdnf tran-
scription results in human cognitive disorders. These include
Cav1.2 (Timothy syndrome), RSK2 (Coffin-Lowry syndrome),
CBP (Rubenstein-Taybi syndrome), MeCP2 (Rett syndrome),
and BDNF itself (memory loss and psychiatric disorders).
The mutation of components of other activity-dependent
gene expression pathways lead to additional cognitive disor-
ders, including especially autism.
wild-type mice results in only a short-lasting form
of LTP elicits a longer-lasting form of LTP in
CREB-VP-16 mice (Barco et al., 2002). However,
since CREB plays a critical role in regulating both
neuronal surival and dendritic outgrowth, it is diffi-
cult to determine from these experiments whether
CREB’s effect on plasticity is secondary to an ef-
fect of CREB on dendritic growth and/or apoptosis.
However, additional evidence in support of a role
for activity-dependent transcription in synaptic plasticity comes
from a study of mice that carry a conditional targeted deletion of
the activity-regulated transcription factor SRF, which reveals
that SRF-deficient mice have defects in LTP at Schaffer collat-
eral-CA1 synapses but no impairment in cell survival (Etkin
et al., 2006; Ramanan et al., 2005). Taken together, the results
described above suggest a critical role for activity-dependent
transcription in experience-driven synaptic development and
function.
Activity-Dependent Transcription and Human Cognition
The symptoms of many disorders of human cognition first pres-
ent during early postnatal development, the time during which
activity-dependent genes are highly induced and experience-
dependent synaptic remodeling is peaking. These observations
raise the possibility that defects in the activity-dependent gene
program could account for some disorders of human cognition.
Consistent with this hypothesis, accumulating evidence has indi-
cated that mutations in a large number of the components of the
activity-dependent gene program give rise to disorders of human
cognition (Figure 4).
BDNF
A polymorphism in the coding region of the human Bdnf gene
(Val66Met) has a profound impact on hippocampal-dependent
memory (Egan et al., 2003; Hariri et al., 2003). Individuals with
this polymorphism not only perform less well in tests of learning
and memory but also have increased susceptibility to a number
of neuropyschiatric disorders, including depression, eating dis-
orders, and bipolar disorder (Neves-Pereira et al., 2002; Ribases
et al., 2003, 2004; Sen et al., 2003; Sklar et al., 2002).
Given that polymorphisms in the Bdnf gene are associated
with impairments in human cognition, it has been hypothesized
that the mutation of components of the pathways that control ac-
tivity-dependent Bdnf promoter IV transcription might also result
in disorders of human cognition. A number of recent studies have
provided significant support for this hypothesis. Mutation of
a subtype of the L-type VSCC (Cav-1.2) is the cause of Timothy
syndrome, a human disorder that results in significant cognitive
Neuron 59, September 25, 2008 ª2008 Elsevier Inc. 855
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(80%), suggesting a critical role for the Cav-1.2 gene in human
cognitive development (Splawski et al., 2004). Likewise, muta-
tion of the CREB cofactor CBP results in Rubinstein-Taybi sy-
drome, a disorder characterized by severe mental retardation
(Petrij et al., 1995). CBP is important for activity-dependent tran-
scription, as it associates with CREB only after CREB has been
phosphorylated at serine-133 and, upon its association with
CREB, increases the transcription of Bdnf. One of the kinases
that phosphorylates CREB on serine-133, RSK2, is mutated in
Coffin-Lowry syndrome, another human disorder that results in
severe mental retardation (Hanauer and Young, 2002). Finally,
mutation of MeCP2, an activity-regulated repressor of BDNF
promoter IV transcription, results in Rett syndrome, a pervasive
developmental disorder characterized by mental retardation
and defects in socialization. A striking feature of Rett syndrome
is that this disorder is first detected within the second year of
life following apparently normal early development. This is the
time when activity-dependent synaptic development is under-
way (Zoghbi, 2003) and raises the possibility that Rett syndrome
is a disorder of activity-dependent gene transcription. Several
features of MeCP2 make this hypothesis compelling. These in-
clude the observations that calcium-dependent phosphorylation
of MeCP2 affects dendritic spine development and loss of
MeCP2 function alters excitatory/inhibitory synaptic balance
(Dani et al., 2005; Zhou et al., 2006). As Rett syndrome is an au-
tism spectrum disorder, these findings on MeCP2 provide the
first compelling evidence that defects in activity-dependent
gene transcription might be a cause of autism.
Other Activity-Dependent Transcription Factors
and Human Cognitive Disorders
If the hypothesis that mutation of genes involved in the activity-
dependent gene regulation program results in human cognitive
disorders is correct, then one would expect that mutation of
pathways in addition to the BDNF pathway would also result in
disorders of human cognition, including autism. A recent study
aimed at identifying genetic loci that are mutated in autism iden-
tified several activity-regulated genes as autism loci. Genetic
analysis of individuals with autism derived from consanguineous
lineages identified two large genomic deletions that cosegre-
gated with autism (Morrow et al., 2008). Strikingly, the deletions
are not within the coding regions of genes but rather appear to
include sequences that control gene expression. The three
genes closest to these deletions are c3orf58, NHE9, and
PCDH10, suggesting that these deletions may cause autism by
interfering with the regulation or function of these genes.
c3orf58 is a gene of unknown function, while PCDH10 encodes
a member of the protocadherin family, which have been impli-
cated in synapse development, and NHE9 encodes for a so-
dium/proton pump that is important for maintaining the proper
balance of ions within neurons. Interestingly, c3orf58, NHE9,
and PCDH10 appear to be activity-regulated genes (Morrow
et al., 2008). c3orf58mRNA is induced by membrane depolariza-
tion of neurons, contains evolutionarily conserved MEF2, CREB,
and SRF binding sites, and its activity-induced transcription is
significantly reduced by interfering with MEF2 function. Similarly,
PCDH10 mRNA is induced by membrane depolarization, and its
856 Neuron 59, September 25, 2008 ª2008 Elsevier Inc.expression is driven by an activated form of MEF2. Finally, NHE9
expression is regulated, at least in part, by the action of the
activity-regulated transcription factor NPAS4.
The observation that the mutations associated with NHE9 and
PCDH10 that were identified in autistic individuals are not
located within the coding region of these genes suggests that
these mutations instead are likely to affect regulatory regions
that control the level of gene transcription of NHE9 and
PCDH10. Thus, these mutations might be expected to not com-
pletely knock out gene function, and this could explain why the
mutations identified in NHE9 and PCDH10 result in autism and
epilepsy and not a more significant mental retardation. It is inter-
esting to speculate that autism and epilepsy may arise from mu-
tations that affect the regulation of genes involved in synapse
development and/or function, while mutations that disrupt the
coding region of genes may cause more severe phenotypes
such as mental retardation. These observations suggest that
as more mutations within the regulatory regions of activity-
dependent genes are discovered they may be found to dispro-
portionately give rise to autism spectrum disorders and epilepsy
as opposed to mental retardation that results from a loss of gene
function.
Concluding Remarks
As described in this review, activity-regulated transcription plays
a crucial role in many different aspects of synaptic development,
and thus a significant amount of effort has gone into elucidating
the molecular pathways that regulate activity-dependent tran-
scription. As more of the components of the signaling network
that controls activity-dependent gene transcription are identi-
fied, and the causal mutations of human cognitive disorders be-
come known, it is striking that there is a large degree of overlap
between the regulators of activity-dependent gene expression
and genes that are mutated in human cognitive disorders.
Nevertheless, we are currently limited by what we know about
human cognitive disorders as well as by our current understand-
ing of the activity-dependent gene regulation program. The work
described above on the activity-dependent transcriptional net-
work and the corresponding human cognitive disorders sug-
gests that extensive characterization of signaling pathways as
well as human mutations has the potential to greatly increase
our understanding of the link between these processes. To this
end, advances in sequencing technology allowing for fast, inex-
pensive, complete sequencing of DNA and RNA in mammalian
cells suggest that the next few years will see an explosion in
the identification of mutations associated with human cognitive
disorders. Similarly, the ability to assess chromatin occupancy
of transcription factors on a genome-wide scale and to use
RNAi to disrupt gene function suggests that the identification
of the targets of activity-regulated transcription factors will not
be far behind. Taken together, these approaches will allow for
a more thorough comparison of the genes involved in disorders
of human cognition and the components of the activity-regulated
gene network. We believe that in the years ahead these avenues
of research will greatly increase our understanding of nervous
system development and also shed light on the etiology of
many disorders of human cognition.
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